Overview
Rogerio Lilenbaum is an Oncologist and a Hematologist in New Haven, Connecticut. Dr. Lilenbaum has been practicing medicine for over 35 years and is rated as an Advanced provider by MediFind in the treatment of Lung Adenocarcinoma. His top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), Lung Cancer, and ALK-Positive Non-Small Cell Lung Cancer.
His clinical research consists of co-authoring 31 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Yale University
Scott Gettinger is an Oncologist and a Hematologist in New Haven, Connecticut. Dr. Gettinger is rated as an Elite provider by MediFind in the treatment of Lung Adenocarcinoma. His top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Small Cell Lung Cancer (SCLC), EGFR Positive Lung Cancer, and Gamma Knife Radiosurgery.
Azadeh Namakydoust is a Hematologist and an Oncologist in Farmington, Connecticut. Dr. Namakydoust is rated as a Distinguished provider by MediFind in the treatment of Lung Adenocarcinoma. Her top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and Squamous Cell Lung Carcinoma.
Baystate Medical Practices Inc
John Mccann is a Hematologist and a Hematologist Oncology provider in Springfield, Massachusetts. Dr. Mccann is rated as a Distinguished provider by MediFind in the treatment of Lung Adenocarcinoma. His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Non-Small Cell Lung Cancer (NSCLC), and Small Cell Lung Cancer (SCLC). Dr. Mccann is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Non-Small Cell Lung Cancer (NSCLC)Dr. Lilenbaum isDistinguished. Learn about Non-Small Cell Lung Cancer (NSCLC).
- Advanced
- ALK-Positive Non-Small Cell Lung CancerDr. Lilenbaum isAdvanced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- EGFR Positive Lung CancerDr. Lilenbaum isAdvanced. Learn about EGFR Positive Lung Cancer.
- Large-Cell Lung CarcinomaDr. Lilenbaum isAdvanced. Learn about Large-Cell Lung Carcinoma.
- Lung AdenocarcinomaDr. Lilenbaum isAdvanced. Learn about Lung Adenocarcinoma.
- Lung CancerDr. Lilenbaum isAdvanced. Learn about Lung Cancer.
- Pleuropulmonary BlastomaDr. Lilenbaum isAdvanced. Learn about Pleuropulmonary Blastoma.
- Experienced
- Liver CancerDr. Lilenbaum isExperienced. Learn about Liver Cancer.
- MesotheliomaDr. Lilenbaum isExperienced. Learn about Mesothelioma.
- Metastatic Brain TumorDr. Lilenbaum isExperienced. Learn about Metastatic Brain Tumor.